Wuhan Muwang Trading
Tirzepatide
Finnrick tested 4 samples of Tirzepatide (GLP-1 and GIP agonist) from Wuhan Muwang Trading between 14 Oct 2025 and 20 Feb 2026. Test scores average over 6, no score below 5, and at least 2 tests warrant a tentative Finnrick Rating of B (Good).
Finnrick Rating™
Tentative Rating
Wuhan Muwang Trading
Tirzepatide
Tested 4 Samples
Last test 20 Feb 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Tirzepatide tests from top-rated vendors:
All Tirzepatide tests from Wuhan Muwang Trading
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
20 Feb 2026
First
14 Oct 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 20 Feb 2026 | View | 5mg | 4.26mg | -14.8% | 99.80% | (no batch ID) | No Label / Silver Crimp / Clear Red Cap | Lab E | Public | |
| 19 Jan 2026 | View | 20mg | 20.2mg | +1.0% | 99.79% | (no batch ID) | No Label / Red Crimp / White Cap | Lab E | Public | |
| 19 Jan 2026 | View | 30mg | 28.5mg | -5.0% | 99.79% | (no batch ID) | No Label / Green Crimp / Pink Cap | Lab E | Public | |
| 14 Oct 2025 | View | 60mg | 59.2mg | -1.3% | 99.60% | (no batch ID) | White Label / Silver Crimp / Clear Pink Cap | Lab G | Public | |